1 / 5

US Benign Prostatic Hyperplasia Procedures Share, Growing Demand

Benign Prostatic Hyperplasia (BPH) is a medical condition in which the prostate gland becomes enlarged. The enlargement of the prostate gland causes urinary tract problems by blocking the flow of urine out of the body. This happens because the prostate gland surrounds the urethra, which is the tube that carries the urine from the urinary bladder to out of the body, and so, the enlargement of the gland squeezes or blocks the urethra, causing discomfort and problems while urinating.

Download Presentation

US Benign Prostatic Hyperplasia Procedures Share, Growing Demand

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Aging Population Driving U.S. Benign Prostatic Hyperplasia Procedures Market Growth 1 © Prescient & Strategic (P&S) Intelligence Pvt. Ltd. All rights reserved

  2. This growth is driven by the rising incidence of BPH and technological enhancements in diagnostic and therapeutic procedures. The disease, wherein the prostate gland becomes enlarged, is common among aging men. The prostate gland surrounds the urethra, and as the prostate enlarges, it can partly block or squeeze the urethra, thus causing trouble while urinating. Receive Sample Copy of this Report: https://www.psmarketresearch.com/market-analysis/us-bph- procedures/report-sample Thus, a key factor propelling the market growth is the booming aging population in the country. Men aged 50 years and above are more susceptible to the disease and, therefore, opt for various BPH treatment procedures. As per the U.S Department of Health and Human Services, the population of people aged 60 and above in the nation rose from 50.7 million to 68.7 million during 2006– 2016. Moreover, the favorable reimbursement scenario for BPH procedures is expected to generate lucrative market opportunities in the coming years. Apart from this, continuous research and development (R&D) activities have led to the production of technologically improved BPH therapies and devices, which is eventually boosting the U.S. benign prostatic hyperplasia procedures market growth. Some of the recently launched the targeted sterile water vapor therapy (Rezum) and prostatic urethral lift (UroLift system). Rezum is a minimally invasive procedure that utilizes steam for the treatment of BPH. Both therapies can be performed in an outpatient facility or clinic, thus reducing the cost incurred due to hospital surgeries and stay. The type segment of the U.S. benign prostatic hyperplasia procedures market is classified into laser-based procedure, surgical procedure, UroLift, and other energy-based procedure. Amongst these, the laser-based procedure category accounted for the largest market share in 2016, as these procedures are more effective than other procedures and less likely to cause complications. The UroLift category will exhibit the fastest growth throughout the forecast period, on account of the low cost of the procedure, booming geriatric population, and expanding insurance coverage for the procedure by numerous insurers. Key players in the U.S. benign prostatic hyperplasia procedures market are launching advanced BHP treatment devices and gaining private and public insurance coverage for a competitive edge. For example, NeoTract Inc., in May 2017, announced that its patent UroLift system is insured by Cigna Insurance Services Co. Other key players offering devices for BPH procedures in the country include Boston Scientific Corporation, Convergent Laser Technologies, NxThera Inc., and Urologix LLC. These companies are also focusing on acquiring other players to provide 2 © Prescient & Strategic (P&S) Intelligence Pvt. Ltd. All rights reserved

  3. innovative equipment for BPH treatment procedures and, in turn, widen their customer base in the U.S. For example, in September 2017, Teleflex Incorporated announced its acquisition agreement with NeoTract Inc. to leverage the potential long-term advantages from the second-generation UroLift system of NeoTract Inc. The widening product portfolio of these companies is, therefore, facilitating the U.S. benign prostatic hyperplasia procedures market growth. Thus, the growing population of the elderly and surging availability of advanced BPH treatment products in the U.S. is expected to fuel the market growth in the coming years. The research offers historical numbers of the BPH proceduresfor the period 2013 – 2016 and procedures forecast for the period 2017 – 2023. U.S. BPH PROCEDURES, BY TYPE Laser based procedure • oGreen light lasers oHolmium lasers oThulium lasers oOthers Surgical procedure • oTransurethral resection of the prostate (TURP) oTransurethral incision of the prostate (TUIP) UroLift Other energy based procedure Transurethral microwave thermotherapy (TUMT) Transurethral needle ablation (TUNA) Rezūm High-intensity focused thermotherapy • • o o o ultrasound (HIFU) and water-induced o 3 © Prescient & Strategic (P&S) Intelligence Pvt. Ltd. All rights reserved

  4. Disclaimer: P&S Intelligence always keeps its customers’ interests at the core while carrying out research activities. P&S Intelligence ensures the reliability and accuracy of information and data provided in its market research publications. However, the information in publications is subject to fluctuations, as it is based on primary interviews of officials from various companies or organizations. P&S Intelligence is not responsible for any incorrect data provided by the key industry players of the concerned domain. The information or analysis in P&S Intelligence publications represents opinions based on research and should not be interpreted as statements of fact. Information in this report was believed to be correct at the time of publication, but cannot be guaranteed. P&S Intelligence does not endorse any product, service, or vendor depicted in its research publications. All intellectual properties, including trademarks and copyrights, belong to their respective owners and may be protected by copyright. Under no circumstance can these be reproduced in any form without prior written agreement of their owners. An order for market research report is intended for internal use of the company only and not for disclosure to third parties or any other publication in general. No service, report, or part thereof provided by P&S Intelligence can be reproduced, republished, resold, revealed, distributed, circulated, or sublicensed in any medium or form now realized or hereafter become realized, including but not limited to, all forms of optical-based media, magnetic, electronic, or digital, without a written permission from Prescient & Strategic Intelligence Pvt. Ltd. 4 © Prescient & Strategic (P&S) Intelligence Pvt. Ltd. All rights reserved

  5. Kindly write to: enquiry@psmarketresearch.com B-13, Sector – 2, Noida, U.P. – 201301, INDIA Contact No: +91 120 4541 337 US/Canada Toll-Free: 1-888-778-7886 5 © Prescient & Strategic (P&S) Intelligence Pvt. Ltd. All rights reserved

More Related